EUVIMEDEUVIMED entdecken
Crossref

Postnatal Fate of Donor Hematopoietic Stem Cells After Transamniotic Stem Cell Therapy

Kamila Moskowitzova, Ashlyn E Whitlock, Ina Kycia, David Zurakowski, Dario O Fauza

Journal of Surgical Research · 2026-05 · 321 · 285-290

DOI: 10.1016/j.jss.2026.03.015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Surgical Research, 2026-05. Verfasst von Kamila Moskowitzova und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Hematopoietic Stem Cells. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: Boston Children's Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Transamniotic Stem Cell Therapy is a minimally invasive alternative for fetal administration of syngeneic/autologous hematopoietic stem cells (HSCs). We sought to examine donor HSC fate after birth following HSC-based Transamniotic Stem Cell Therapy in a healthy syngeneic model. METHODS Sixteen time-dated pregnant Lewis dams underwent volume-matched intra-amniotic injections in all fetuses (n = 124) of either donor HSCs labeled with a firefly luciferase reporter gene (HSC; n = 81) or of acellular luciferase (control; n = 43) on gestational day 17 (E17, term = E21-22). Infused HSCs consisted of syngeneic cells with hematopoietic progenitor identity confirmed by flow cytometry. On postnatal days 7 (P7) and 21 (P21) after birth, samples from 10 neonatal anatomical sites were screened for luciferase activity via microplate luminometry. Maternal samples of serum and bone marrow were screened at either P7 or P21. RESULTS Overall survival to term was 44% (54/124). Combined survival to P7 and P21 from term was 72% (39/54), with no significant difference between groups (P = 0.22-1.00). When controlled by the acellular luciferase injections, donor HSCs were identified in the spleen, intestine, liver, and brain on P7 (P = 0.032 to 0.002) but in none of the sites in any neonate on P21. No luciferase activity was detected in any maternal sample. CONCLUSIONS Although present 1 wk after birth at select neonatal sites, donor HSCs are not detectable at 3 wk of postnatal life after intra-amniotic injection in a healthy syngeneic rodent model, suggesting that transamniotic HSC therapy may be safe and thus amenable to eventual regulatory approval for clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationHematopoietic Stem CellsAnimalsFemalePregnancyRats, Inbred LewAnimals, NewbornAmnionRats

Stichwörter der Autor:innen

Amniotic stem cellFetal cell therapyFetal hematopoietic stem cell therapyHematopoietic stem cellIn utero cell therapyTRASCETTransamniotic stem cell therapy

Autor:innen und Institutionen

  • Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: dario.fauza@childrens.harvard.edu.

Förderung

  • Boston Children's Hospital

Zitieren

APA

Moskowitzova, K., Whitlock, A. E., Kycia, I., Zurakowski, D., & Fauza, D. O. (2026). Postnatal Fate of Donor Hematopoietic Stem Cells After Transamniotic Stem Cell Therapy. Journal of Surgical Research, 321, 285-290. https://doi.org/10.1016/j.jss.2026.03.015

Vancouver

Moskowitzova K, Whitlock AE, Kycia I, Zurakowski D, Fauza DO. Postnatal Fate of Donor Hematopoietic Stem Cells After Transamniotic Stem Cell Therapy. Journal of Surgical Research. 2026;321:285-290. doi:10.1016/j.jss.2026.03.015

BibTeX
@article{Moskowitzova2026,
  author = {Moskowitzova, Kamila and Whitlock, Ashlyn E and Kycia, Ina and Zurakowski, David and Fauza, Dario O},
  title = {Postnatal Fate of Donor Hematopoietic Stem Cells After Transamniotic Stem Cell Therapy},
  journal = {Journal of Surgical Research},
  year = {2026},
  volume = {321},
  pages = {285--290},
  doi = {10.1016/j.jss.2026.03.015}
}
Kostenlos starten →